As of 4:00pm ET
| +0.05 / +0.25%|
The 7 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 29.00, with a high estimate of 60.00 and a low estimate of 16.00. The median estimate represents a +42.86% increase from the last price of 20.30.
The current consensus among 8 polled investment analysts is to Buy stock in Acorda Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.